RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one

Bibliographic Details
Main Authors: Rodolfo P. Rothlin, Facundo Pelorosso, Mariano Duarte, Liliana Nicolosi, Ignacio Fernandez Criado, María Victoria Salgado, Héctor Vetulli
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:Revista Portuguesa de Cardiologia
Online Access:http://www.sciencedirect.com/science/article/pii/S0870255123004596